Exploration of anti-atherosclerotic activity of 1,8-cineole through network pharmacology, molecular docking, and in vivo efficacy studies in high-fat-diet-induced atherosclerosis in hamsters
- PMID: 39463214
- DOI: 10.1007/s11030-024-11015-3
Exploration of anti-atherosclerotic activity of 1,8-cineole through network pharmacology, molecular docking, and in vivo efficacy studies in high-fat-diet-induced atherosclerosis in hamsters
Abstract
The anti-atherogenic potential of liver X receptors (LXRs) has been attributed to their inhibitory role in macrophage-mediated inflammation and promotion of reverse cholesterol transport. This study aimed to evaluate the efficacy of an LXR agonist, 1,8-cineole (Eucalyptol), in atherosclerosis through network pharmacology, molecular docking, and in vivo efficacy studies in high-fat-diet-induced atherosclerosis in hamsters. Network pharmacology analysis was performed by identifying potential targets of 1,8-Cineole and atherosclerosis, followed by the construction of component-target-disease and protein-protein interaction networks. Gene Ontology and KEGG pathway enrichment analysis of targets were performed. The top 5 targets were selected for molecular docking studies. Atherosclerosis was induced in male Golden Syrian hamsters, and the results of network pharmacology were verified. Fifty-one overlapped targets were identified for 1,8-cineole and atherosclerosis. In the protein-protein interaction studies, the top 5 ranked proteins were PPARG, FXR, ABCA-1, ABCG1, and LXRΑ. KEGG pathway analysis and molecular docking showed that ABCA-1 and LXRΑ were correlated in atherosclerosis. Animal studies showed amelioration of atherosclerotic lesions in the aorta of animals treated with 1,8-cineole compared to disease control aortas. A dose-dependent attenuation in ABCA-1 levels and inflammatory markers was observed in animals treated with 1,8-cineole, comparable to its levels in normal animals. In conclusion, 1,8-cineole showed anti-atherosclerotic effects in Golden Syrian hamsters via LXRΑ-induced ABCA-1 overexpression.
Keywords: 1,8-cineole; ABCA-1; Atherosclerosis; LXR agonist.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Arctium lappa leaves based on network pharmacology and experimental validation attenuate atherosclerosis by targeting the AMPK-mediated PPARG/LXRα pathway.Biomed Pharmacother. 2022 Sep;153:113503. doi: 10.1016/j.biopha.2022.113503. Epub 2022 Aug 16. Biomed Pharmacother. 2022. PMID: 36076592
-
Evaluation of anti-atherosclerotic activities of PPAR-α, PPAR-γ, and LXR agonists in hyperlipidemic atherosclerosis-susceptible F(1)B hamsters.Atherosclerosis. 2011 Jan;214(1):86-93. doi: 10.1016/j.atherosclerosis.2010.10.033. Epub 2010 Nov 2. Atherosclerosis. 2011. PMID: 21093860
-
QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-ABCA1 pathway.J Ethnopharmacol. 2023 Oct 28;315:116684. doi: 10.1016/j.jep.2023.116684. Epub 2023 May 24. J Ethnopharmacol. 2023. PMID: 37230281
-
Liver X receptor: a potential target in the treatment of atherosclerosis.Expert Opin Ther Targets. 2022 Jul;26(7):645-658. doi: 10.1080/14728222.2022.2117610. Epub 2022 Sep 5. Expert Opin Ther Targets. 2022. PMID: 36003057 Review.
-
Liver X receptors as potential therapeutic targets in atherosclerosis.Clin Invest Med. 2009 Oct 1;32(5):E383-94. doi: 10.25011/cim.v32i5.6927. Clin Invest Med. 2009. PMID: 19796580 Review.
References
-
- Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL (2024) Heart disease and stroke statistics: a report of US and Global Data From the American Heart Association. Circulation [Internet]. [cited 2024 Sep 23];149 Available from https://doi.org/10.1161/CIR.0000000000001209
-
- Kosmas CE, Pantou D, Sourlas A, Papakonstantinou EJ, Uceta RE, Guzman E (2021) New and emerging lipid-modifying drugs to lower LDL cholesterol. Drugs Context, 10.
-
- Griffett K, Burris TP (2023) Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases. Front Med 10:1102469 - DOI
Grants and funding
LinkOut - more resources
Full Text Sources